Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;96(5):E137-E140.
doi: 10.1002/ajh.26109. Epub 2021 Feb 11.

Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib

Preetesh Jain  1 , Rashmi Kanagal-Shamanna  2 , Shaojun Zhang  3 , Chi Young Ok  2 , Lucy Navsaria  1 , Loretta Nastoupil  1 , Hun Ju Lee  1 , Guilin Tang  2 , C Cameron Yin  2 , Maria Badillo  1 , Ranjit Nair  1 , Shaoying Li  2 , Keyur M Patel  2 , Christopher Flowers  1 , Francisco Vega  2 , Linghua Wang  3 , Michael L Wang  1
Affiliations
Free article

Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib

Preetesh Jain et al. Am J Hematol. .
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Witzig TE, Inwards D. Acalabrutinib for mantle cell lymphoma. Blood. 2019;133(24):2570-2574.
    1. Awan FT, Schuh A, Brown JR, et al. Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib. Blood Adv. 2019;3(9):1553-1562.
    1. Wang M, Rule S, Zinzani PL, et al. Long-term follow-up of Acalabrutinib Monotherapy in patients with relapsed/refractory mantle cell lymphoma. Blood. 2018;132(Suppl 1):2876-2876.
    1. Martin P, Maddocks K, Leonard JP, et al. Postibrutinib outcomes in patients with mantle cell lymphoma. Blood. 2016;127(12):1559-1563.
    1. Jain P, Kanagal-Shamanna R, Zhang S, et al. Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. Br J Haematol. 2018;183(4):578-587.

MeSH terms

LinkOut - more resources